MGD024

· MacroGenics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MGD024, covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]